【レポートの概要（一部）】
1. Analyst View
2. Research Methodology
3. Current Radiation Therapies
3.1 Third Dimensional Conformal Therapy (CRT)
3.2 Image Guided Radiotherapy (IGRT)
3.3 Intensity Modulated Radiotherapy (IMRT)
3.4 Stereotactic Radiotherapy
3.5 Neutron Therapy
3.6 Proton Therapy
3.6.1 Why Proton Therapy?
4. Components of a Standard Proton Therapy Center
4.1 Proton Accelerator
4.2 Beam Transport System
4.3 Beam Delivery System
4.4 Nozzle
4.4.1 Single Scattering
4.4.2 Double Scattering
4.4.3 Uniform Scanning Nozzle
4.4.4 Pencil Scanning Nozzle
4.5 Treatment Planning System
4.6 Image Viewers
4.7 Patient Positioning System
4.8 Human Resource
5. Proton Therapy: Geographic Assessment to 2018
5.1 Japan
5.1.1 Demographics
5.1.2 Macro-Economic Indicators
5.1.3 Disease Profiling
5.1.4 Current Status of Proton Therapy
5.1.5 Opportunity Assessment
5.2 Germany
5.2.1 Demographics
5.2.2 Macro-Economic Indicators
5.2.3 Disease Profiling
5.2.4 Current Status of Proton Therapy
5.2.5 Opportunity Assessment
5.3 China
5.3.1 Demographics
5.3.2 Macro-Economic Indicators
5.3.3 Disease Profiling
5.3.4 Current Status of Proton Therapy
5.3.5 Opportunity Assessment
5.4 UK
5.4.1 Demographics
5.4.2 Macro-Economic Indicators
5.4.3 Disease Profiling
5.4.4 Current Status of Proton Therapy
5.4.5 Opportunity Assessment
6. Competitive Landscape and Strategic Analysis
6.1 IBA
6.2 Hitachi
6.3 Varian
6.4 Mitsubishi
6.5 Sumitomo Heavy Industries
List of Figures:
Figure 3-1: Advantages of Proton Therapy over Conventional Radiation Therapy
Figure 4-1: Investment Break-up for a Proton Therapy Center
Figure 4-2: Maximum Number of Patients that can be treated based on Number of Rooms
Figure 4-3: Components of a Proton Therapy Center
Figure 5-1: Japan – Population (Million), 2013-2018
Figure 5-2: Japan – Age-wise Breakup of Population (%), 2013 & 2018
Figure 5-3: Japan – Number of Households (Million), 2013-2018
Figure 5-4: Japan – Nominal GDP (Trillion US$), 2013-2018
Figure 5-5: Japan – Personal Disposable Income per Head (US$), 2013-2018
Figure 5-6: Japan – Number of Households Earning > US$ 75,000 p.a. (Million), 2013-2018
Figure 5-7: Japan – Cancer Incidence (000), 2009 & 2020
Figure 5-8: Japan – Number of Proton Therapy Centers (2013 & 2018)
Figure 5-9: Japan – Proton Therapy Centers by Number of Rooms (2013 & 2018)
Figure 5-10: Japan – Demand of Single Room Proton Therapy Centers by 2018
Figure 5-11: Germany – Population (Million), 2013-2018
Figure 5-12: Germany – Age-wise Breakup of Population (%), 2013 & 2018
Figure 5-13: Germany – Number of Households (Million), 2013-2018
Figure 5-14: Germany – Nominal GDP (Trillion US$), 2013-2018
Figure 5-15: Germany – Personal Disposable Income per Head (US$), 2013-2018
Figure 5-16: Germany – Number of Households Earning > US$ 75,000 p.a. (Million), 2013-2018
Figure 5-17: Germany – Cancer Incidence (000), 2009 & 2020
Figure 5-18: Germany – Number of Proton Therapy Centers (2013 & 2018)
Figure 5-19: Germany – Proton Therapy Centers by Number of Rooms (2013 & 2018)
Figure 5-20: Germany – Demand of Proton Therapy Centers by 2018
Figure 5-21: China – Population (Million), 2013-2018
Figure 5-22: China – Age-wise Breakup of Population (%), 2013 & 2018
Figure 5-23: China – Number of Households (Million), 2013-2018
Figure 5-24: China – Nominal GDP (Trillion US$), 2013-2018
Figure 5-25: China – Personal Disposable Income per Head (US$), 2013-2018
Figure 5-26: China – Number of Households Earning > US$ 75,000 p.a. (Million), 2013-2018
Figure 5-27: China – Cancer Incidence (Million), 2009 & 2020
Figure 5-28: China – Number of Proton Therapy Centers (2013 & 2018)
Figure 5-29: China – Proton Therapy Centers by Number of Rooms (2013 & 2018)
Figure 5-30: China – Demand of Proton Therapy Centers by 2018
Figure 5-31: UK – Population (Million), 2013-2018
Figure 5-32: UK – Age-wise Breakup of Population (%), 2013 & 2018
Figure 5-33: UK – Number of Households (Million), 2013-2018
Figure 5-34: UK – Nominal GDP (Trillion US$), 2013-2018
Figure 5-36: UK – Number of Household Earning > US$ 75,000 p.a. (Million), 2013-2018
Figure 5-37: UK – Cancer Incidence (Million), 2011 & 2020
Figure 5-40: UK – Demand of Proton Therapy Centers by 2018
Figure 6-1: IBA – Breakdown of Revenue by Activity (%), 2013
List of Tables:
Table 4-1: Capital Investment and Land Requirement for Proton Therapy Center
Table 4-2: Human Resource Requirements and their role in Proton Therapy Center
Table 5-1: Japan – Top 15 Cancer Types by Incidence (2009)
Table 5-2: Japan – Top 15 Cancer Types by Mortality (2009)
Table 5-3: Japan – Existing Proton Therapy Facilities (2013)
Table 5-4: Japan – Upcoming Proton Therapy Facilities (2014-2018)
Table 5-5: Japan – Potential Patients for Proton Therapy (2013 & 2018)
Table 5-6: Germany – Top 15 Cancer Types by Incidence (2009)
Table 5-7: Germany – Top 15 Cancer Types by Mortality (2009)
Table 5-8: Germany – Existing Proton Therapy Facilities (2013)
Table 5-9: Germany – Upcoming Proton Therapy Facilities (2014-2018)
Table 5-10: Germany – Potential Patients for Proton Therapy (2013 & 2018)
Table 5-11: Germany – List of Potential Hospitals
Table 5-12: China – Top 15 Cancer Types by Incidence (2009)
Table 5-13: China – Top 15 Cancer Types by Mortality (2009)
Table 5-14: China – Existing Proton Therapy Facilities (2013)
Table 5-15: China – Upcoming Proton Therapy Facilities (2014-2018)
Table 5-16: China – Potential Patients for Proton Therapy (2013 & 2018)
Table 5-17: China – List of Potential Hospitals
Table 5-18: UK – Top 10 Cancer Types by Incidence (2011)
Table 5-19: UK – Top 10 Cancer Types by Mortality (2011)
Table 5-20: UK – Upcoming Proton Therapy Facilities (2014-2018)
Table 5-21: UK – Potential Patients for Proton Therapy (2013 & 2018)
Table 6-1: IBA – Proton Therapy Products and Services
Table 6-2: IBA – Key Financials (Million EUR), 2011-2013
Table 6-3: IBA – Proton Therapy Installations
Table 6-4: IBA – Strengths and Weaknesses
Table 6-5: Hitachi – Key Financials (Billion US$), 2011-2013
Table 6-6: Hitachi – Proton Therapy Installations
Table 6-7: Hitachi – Strengths and Weaknesses
Table 6-8: Varian – Proton Therapy Products and Services
Table 6-9: Varian – Key Financials (Billion US$), 2011-2013
Table 6-10: Varian – Proton Therapy Installations
Table 6-11: Varian – Strengths and Weaknesses
Table 6-12: Mitsubishi – Key Financials (Billion Yen), 2011-2013
Table 6-13: Mitsubishi – Proton Therapy Installations
Table 6-14: Mitsubishi – Strengths and Weaknesses
Table 6-15: Sumitomo – Key Financials (Billion Yen), 2011-2013
Table 6-16: Sumitomo – Proton Therapy Installations
Table 6-17: Sumitomo – Strengths and Weaknesses
【レポート販売概要】
■ タイトル：世界の陽子線治療（Proton Therapy）市場（～2018）■ 英文：Global Proton Therapy Outlook 2018
■ 発行日：2014年6月
■ 調査会社：RNCOS
■ 商品コード：RNCOS-4060115
■ 調査対象地域：グローバル
- 2014年戦略提言：ドイツの臨床化学・免疫診断市場Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.“2014 Strategies for the German Clinical Chemistry and Immunodiagnostic Market” is a new strategic analysis of major business opportunities emerging in the German clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the Ge …
- テニスラケットの世界市場2016-2020About Tennis Racquet While traditional tennis rackets were made of wood and strings, manufacturers now use carbon fiber and aluminum as primary raw materials. The size, design, length, stiffness of the frame, balance, and weight of a tennis racket play significant roles in enhancing player strength and performance. Manufacturers consider these features key to the successful R&D of these rackets an …
- 拡張現実市場分析と予測（Augmented Reality: Global Market Analysis and Forecast 2012 – 2017）Augmented Reality (AR) is a live, direct or indirect, view of a physical, real-world environment whose elements are augmented by computer-generated sensory input, that enrich the user's perception of the real world. Although AR is often perceived to be in the visual domain (video or graphics etc), it actually includes the other senses as well such as sound or GPS data. The popularity of smartphone …
- Cymbalta（神経因性疼痛）：医薬品市場予測及び分析（～2022）Cymbalta (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although t …
- 臭素の世界市場：有機臭素、臭化水素酸、清澄塩水The market size for bromine is projected to reach USD 9.82 Billion by 2021, registering a CAGR of 12.4% between 2016 and 2021. Increasing demand from the end-use applications such as flame retardants, oil & gas drilling activities, biocides, and PTA synthesis are the major drivers for bromine market. The automotive, water treatment, electronics, and oil & gas industries are growing in the emerging …
- 電着塗装（E-Coat）の世界市場：陰極エポキシ塗料、陰極アクリル塗料、陽極塗料The e-coat market size is estimated to reach USD 3.80 Billion by 2021, registering a CAGR of 4.34% between 2016 and 2021. The market witnessed moderate growth in the past few years and the same trend is expected to continue in the near future. This growth is driven by the rising automotive and appliances industries. In addition, growing manufacturing activities have also been driving the market. T …
- Ranirestat (Microvascular Complications of Diabetes)：市場予測と分析（～2022）Ranirestat (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the spars …
- マイクロサーバの世界市場The total microserver market is expected to grow from $1.92 billion in 2014 to $16.31 billion by 2019, at an estimated Compound Annual Growth Rate (CAGR) of 53.4% from 2014 to 2019. Although the technologically advanced markets such as the NA and the Europe hold larger share in the microserver market, the Asia-Pacific region is expected to grow at the highest CAGR of 58.4% during the forecast peri …
- 自動車補修用塗料の世界市場2016-2020：溶剤型塗料、水性塗料About Automotive Refinish CoatingsAutomotive coatings are products that enhance the exterior appearance and durability of a vehicle by protecting it from harsh external factors such as UV radiation, heat and cold, and grit from the road. Automotive refinish coatings are used for automotive aftermarket purposes such as vehicle repair and refinishing. Technavio’s analysts forecast the global automot …
- 皮膚診断デバイスの世界市場The global dermatology diagnostic devices market is estimated to grow at a CAGR of 8.2% from 2014 to 2019. North America and Europe hold larger shares in the global dermatology diagnostic devices market. The growth of the global dermatology diagnostic devices market is mainly attributed to a wide range of factors, such as increasing incidence of skin disorders, growing demand of dermatologists, an …
- モバイルアプリテストサービスの世界市場2017-2021About Mobile Application Testing (MAT) Services Software testers face many challenges while developing innovative and error-free software products and applications. They require IT solutions that can minimize the cost of testing services and enhance the quality of software. Rapid changes in technology and increasing mobility solutions compel software developers to consider testing as an important …
- フランスの水力発電市場2016：発電能力、生産、投資動向、制度、企業Hydropower in France, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary "Hydropower in France, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles” is the latest report from GlobalData, the industry analy …
- グローバル・多嚢胞性卵巣症候群(PCOS)治療薬市場動向（2014-2018）About PCOS Drugs PCOS, also known as Stein-Leventhal Syndrome, is one of the most common hormonal endocrine disorders in women. It is characterized by polycystic ovaries, irregular or no menstrual periods, irregular ovulation, and high levels of androgens (male hormones) in the body. The exact cause of PCOS is unknown. In PCOS, small cysts form on the ovaries, which do not produce a sufficient amo …
- 公共安全スペクトラム及びシステム市場動向PPDR usage worldwide is concentrated on a limited number of frequency bands. Among them, the 400 MHz is the most currently used for narrowband systems. At the WRC-15 in November 2015, a decision is to be taken on allocation of frequencies for broadband PPDR spectrum. The 700 MHz is the best candidate at world level, with distinct scenarios being considered. TETRA-like narrowband networks have serv …
- 情報漏洩防止(DLP)の世界市場2018-2022About Data Loss Prevention The global DLP market provides cloud and network-based solutions for devices such as mobile devices, laptops, and USB drivers. It also helps enterprises to comply with internal policies, achieve government’s regulatory policies, and prevent disclosure of sensitive data. Technavio’s analysts forecast the global data loss prevention market to grow at a CAGR of 23.78% durin …
